Evaluation of interleukin-2 production and interleukin-2 receptor expression in dogs with generalized demodicosis

Veterinary Dermatology

Volumn 7, Issue 4, 1996, Pages 213-219

  Lemarié, Stephen L ^a,b   Horohov, David W ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Canine; Generalized demodicosis; Interleukin 2

Indexed keywords

CANIS FAMILIARIS;

EID: 4243082457     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3164.1996.tb00249.x     Document Type: Review

References (36)

1. Scott, D. W., Farrow, B. R. H., Schultz, R. D. Studies on the therapeutic and immunologic aspects of generalized demodectic mange in the dog. Journal of the American Animal Hospital Association 1974; 10: 233.
2. Owen, L. N. Transplantation of canine osteosarcoma. European Journal of Cancer 1969; 5: 615.
3. Scott, D. W. Demodicosis. In: Kirk, R.W., ed. Current Veterinary Therapy, 5th edn. Philadelphia: W.B. Saunders Company, 1995: 417-32.
4. Corbett, R. B., Banks, K. et al. Cellular immune responsiveness in dogs with demodectic mange. Transplant Proceedings 1975; 7: 557.
5. Hirsch, D. C., Baker, B. B., Wiger, N. et al. Suppression of invitro lymphocyte transformation by serum from dogs with generalized demodicosis American Journal of Veterinary Research 1975; 36: 1591.
6. Scott, D. W., Schultz, R. D., Baker, E. et al. Further studies on the therapeutic and immunologic aspects of generalized demodectic mange in the dog. Journal of the American Animal Hospital Association 1976; 12: 203.
7. Barta, O., Waltman, C., Oyekan, P. A. et al. Lymphocyte transformation suppression caused by pyoderma failure to demonstrate it in uncomplicated demodectic mange. Comparative Immunology, Microbiology and Infectious Diseases 1983; 6: 9.
8. Barriga, O. O., Al-Khalidi, N. W., Martin, S., Wyman, M. Evidence of immunosuppression by Demodex canis. Veterinary Immunology and Immunopathology 1992; 32: 37-46.
9. Bell, T. G., Farris, R. A. A discourse and proposal on the genesis of generalized demodectic mange: a theory of production of lesions through an immunosuppressive mechanism. Western Veterinarian 1973; 1: 21.
10. Healy, M. C., Gaafar, S. M. Immunodeficiency in canine demodectic mange. II. Skin reactions to phytohemagglutinin and concanavalin A. Veterinary Parasitology 1977b; 3: 133.
11. Corbett, R. B., Perryman, L. E., Gorham, J. R. et al. The cell-mediated immune response: its inhibition and in vitro reversal in dogs with demodectic mange. Federation Proceedings. 1976; 35: 589.
12. Mosmann, T. R., Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review in Immunology 1989; 7: 145.
13. Helfand, S. C., Modiano, J. F., Nowell, P. C. Immunophysiological studies of interleukin-2 and canine lymphocytes. Veterinary Immunology and Immunopathology 1992; 33: 1.
14. Somberg, R. L., Robinson, J. P., Felsburg, P. J. Detection of canine interleukin- 2 receptors by flow cytometry. Veterinary Immunology and Immunopathology 1992; 33: 17.
15. Barta, O., Oyekan, P. P., Waltman, C. Manual of Veterinary Clinical Immunology. School of Veterinary Medicine, LSU, Baton Rouge, LA, 1981.
16. Ohara, J., Paul, W. E. Up-regulation of interleukin 4/ B-cell Stimulatory factor 1 receptor expression. Proceedings of the National Academy of Science USA 1988; 85: 8221.
17. Cantrell, D. A., Smith, K. A. The interleukin-2 T cell system: a new cell growth model. Science 1984; 224: 1312.
18. Brandhuber, B. J., Boons, T., Kenney, W. C., McKay, D. B. Three dimensional structure of interleukin-2. Science 1987; 238: 1707.
19. Daemen, A. J. J. M., Buurman, C. J., Linden, Groenewegen, G., Kootstra, G. Canine IL-2: characterization and optimal conditions for production. Veterinary Immunology and Immunopathology 1984; 5: 247-58.
20. Elmslie, R. E., Dow, S. W., Ogilvie, G. K. Interleukins: biological properties and therapeutic potential. Journal of Veterinary Internal Medicine 1991; 5: 283-93.
21. Uchiyama, T., Broder, S., Waldmann, T. A. A monoclononal antibody (anti tac) reactive with activated and functionallly mature human T cells. Journal of Immunology 1981; 126: 1393-7.
22. Tsudo, M., Kozak, R. W., Goldman, C. K., Waldmann, T. A. Demonstration of a non-tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proceedings of the National Academy of Science USA 1986; 83: 9694-8.
23. Sharon, M., Klausner, R. D., Cullen, B. R., Chizzonite, R., Leonard, W. J. Novel interleukin-2 receptor subunit detected by cross-linking under high affinity conditions. Science 1986; 234: 859-63.
24. Takeshita, T., Asao, H., Ohtani, K. et al. Cloning of the γ chain of human IL-2 receptor. Science 1992; 257: 379-82.
25. Hatakeyama, M., Tsudo, M., Minamoto, S. et al. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science 1989; 244: 551-6.
26. Waldmann, T. A. The structure, function and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 1986; 232: 727-32.
27. Waldmann, T. A. The multi-subunit interleukin-2 receptor. Annual Review of Biochemistry 1989; 58: 875-911.
28. Tsudo, M., Goldman, C. K., Bongiovanni, K. F. et al. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proceedings of the National Academy of Science USA 1987; 84: 5394-8.
29. Tizard, I. Veterinary Immunology: an Introduction, 4th edn. Philadelphia: W.B. Saunders, 1992: 76.
30. Smith, K. A. Interleukin-2 inception, impact, and implications. Science 1988; 240: 1169-76.
31. Mosmann, T., Yokota, T., Kastelein, R. et al. Species specificity of T cell stimulating activities of IL-2 and BSF-1 (IL-4): comparison of normal and recombinant mouse and human IL-2 and BSF-1 (IL-4). Journal of Immunology 1987; 138: 1813-6.
32. Tapia, F. J., Caceres-Dittmar, G., Sanchez, M. A. Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis. Immunology Today 1994; 15: 160-4.
33. Vowels, B. R., Cassin, M., Vonderheid, E. C., Rook, A. H. Aberrant cytokine production by sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. Journal of Investigative Dermatology 1992; 99: 90-4.
34. Yamamura, M., Uyemura, K., Deans, R. J. et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-9.
35. van Reijsen, F. C., Bruijnzeel-Koomen, C. A. F. M., Kalthoff, F. S. et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology.. 1992; 90: 184-92.
36. Schlaak, J. F., Baslau, M., Jochum, W. et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. Journal of Investigative Dermatology 1994; 102: 145-9.